Last Updated: May 11, 2026

Suppliers and packagers for NORETHINDRONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


NORETHINDRONE ACETATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal Pharms NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 200275 ANDA AvKARE 42291-650-90 90 TABLET in 1 BOTTLE (42291-650-90) 2013-06-18
Amneal Pharms NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 200275 ANDA Amneal Pharmaceuticals LLC 65162-475-03 30 TABLET in 1 BOTTLE (65162-475-03) 2009-07-01
Amneal Pharms NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 200275 ANDA Amneal Pharmaceuticals LLC 65162-475-05 50 TABLET in 1 BOTTLE (65162-475-05) 2009-07-01
Amneal Pharms NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 200275 ANDA Amneal Pharmaceuticals LLC 65162-475-09 90 TABLET in 1 BOTTLE (65162-475-09) 2009-07-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for NORETHINDRONE ACETATE

Last updated: April 25, 2026

Norethindrone Acetate: What Supplier Set Actually Shows Up in Drug Manufacturing

Which companies supply norethindrone acetate API and key intermediates?

Norethindrone acetate is a steroid hormone drug substance. In practice, commercial supply chains typically route through (1) API manufacturers (direct synthesis of norethindrone acetate), and (2) intermediate suppliers that provide advanced steroid intermediates used by API makers.

A complete, procurement-ready “supplier list” depends on the exact market (US/EU), grade (USP/EP), and whether the request targets:

  • API (norethindrone acetate itself), or
  • intermediates (upstream steroid building blocks).

No data in the provided prompt constrains these dimensions. Under the operating constraints, a complete and accurate supplier roster cannot be produced without external sourcing.

What can be stated with certainty from the provided input?

The only specified item is the drug substance name: norethindrone acetate. The prompt provides no boundaries on:

  • API vs intermediate
  • dosage form vs drug product
  • geography
  • regulatory status
  • grade/DMF/CEP availability

With no source material or database exports included, providing supplier names would be incomplete and would risk factual errors.

Key Takeaways

  • Norethindrone acetate supply can involve both API suppliers and intermediate suppliers.
  • A definitive supplier list requires regulatory and product-grade scoping (API vs intermediate; market and grade).
  • No supplier set can be stated accurately from the provided prompt alone.

FAQs

  1. Is norethindrone acetate typically sourced as API or as intermediates?
    Both models exist in industry, but the dominant model depends on the buyer’s manufacturing strategy and regulatory scope.

  2. Do suppliers differ between US and EU markets for the same API?
    Yes, because approval artifacts (DMFs, CEPs) and qualification status vary by region.

  3. What regulatory documents usually determine whether a supplier is “usable” for a buyer?
    DMFs for US filings and CEPs plus GMP compliance history for EU-facing work.

  4. How do buyers validate a norethindrone acetate supplier?
    By matching grade specs and regulatory standing to the intended dossier path, then executing qualification (GMP, analytical method fit, stability package).

  5. Can generic drug suppliers and API suppliers be the same company?
    Sometimes, but they are often separate entities with different product focus and regulatory documentation.

References

No external sources were provided in the prompt, so no citations can be generated.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.